Manufacturing Locations

Decatur, Illinois

• Employees – 200
• Product Types
  • 1mL Fill / 2 mL Vial to 100 mL Vial Sterile Filled Liquid Injectables
  • 1 mL to 20 mL Ampoules Sterile Filled Liquid Injectables
  • 5 mL to 100 mL Vial Sterile Lyophilized Injectables
  • 2 mL Fill / 6cc to 30 mL Ophthalmic Bottle Sterile Filled Liquid
  • Prescription, OTC, and Controlled Drug Substance Products
• Core Competencies
  • Terminally Sterilized Products
  • Aseptically Processed Products
  • Lyophilization
  • Controlled Substance Manufacture (Scheduled CII, CIII, CIV)
  • Sterile Liquid Formulations
  • Automated Inspection and Packaging
  • Specialized Products (with sensitivities to light, metal, oxygen, temperature)
• Throughput Capacity
  • Four (4) Sterile Fill Suites
  • Two (2) 220 square foot Lyophilizer chambers with fully automated loading and unloading
  • Three (3) Formulation / Compounding Operations
  • Fully Equipped Quality Control / Micro Laboratories
  • Six (6) Packaging Lines
  • Two (2) Shift Capability
  • Planned Capacity for Thirty (30) Million Filled Units per Year
  • Warehousing for All Types of Products

Somerset, New Jersey

• Employees – 100
• Product Types
  • 5 mL to 30 mL Sterile Filled Gels
  • 1 g to 3.5 g Sterile Filled Ointments
  • 5 mL to 30 mL Sterile Ophthalmic Solutions
  • Prescription and OTC Products
• Core Competencies
  • Aseptically Sterilized Products
  • Sterile Formulations
  • Automated Inspection and Packaging
• Throughput Capacity
  • Two (2) Sterile Fill Suites
  • Two (2) Formulation / Compounding Operations
  • Fully Equipped Quality Control / Micro Laboratories
  • Two (2) Packaging Lines
  • Two (2) Shift Capability
  • Planned Capacity for Twenty Three (23) Million Filled Units per Year

Paonta Sahi, India

• Employees – 1000
• Manufacturing Capabilities
  • General Injectables (non-potent molecules)
    • Aseptic and terminally sterilized molecules as liquids and powders
  • Cephalosporins
    • Aseptic filling of sterile cephalosporin powders (including manufacture of certain oral cephalosporins)
  • Hormones
    • Aseptic and terminally sterilized hormones
  • Carbapenems
    • Aseptic filling of sterile carbapenem powders
  • Ophthalmics
    • Aseptic filling of sterile liquids into three-piece ophthalmic bottles
  • Presentations
    • Sterile: Liquids and powders in vials, ampoules, and three-piece ophthalmic bottles
    • Oral: Tablets, capsules, and powder
• R & D Capabilities
  • Analytical method Development and Validation
  • Analytical support for release and stability
  • Technology Transfer
  • Process Development
  • Stability Services
  • Global Regulatory Support
  • Integrated project management

Operating Locations

Gurnee, Illinois
Akorn operates a central warehouse and distribution facility at 5605 Centerpoint Court, Suite B, Gurnee, Illinois. This facility is licensed by local and state authorities, and has been successfully inspected by the U.S. Food and Drug Administration (FDA).

At this site, we distribute Akorn product s manufactured at our Somerset, New Jersey and Decatur, Illinois as are products manufactured for Akorn, by internationally based contract manufacturers.

Our Gurnee warehouse operations provide state of the art handling and storage process for both refrigerated and non-refrigerated finished drug products-many of which are registered and approved as USP grade products from the newly constructed facility. Our workforce of utilizes both trucking and air freight carriers to distribute products to major U.S. wholesalers, distributors, and individual customer accounts – along with selected distribution to establish international markets.

Skokie, Illinois
In 2010, Akorn opened its new R&D Center in Skokie, Illinois. The facility provides leading edge capabilities for the development of both new and generic pharmaceuticals. The center’s technology and equipment will enable Akorn to expedite its development programs, bringing a number of new products of the Company. The center was designed with the leading-edge equipment and improvements to streamline the R&D process.

The R&D Center supports programs for a variety of pharmaceutical platforms in both ophthalmic and injectable drug products. Akorn's new facility is focused on both the formulation and analytical components of product development. Formulation is an important step in the process, providing a critical link between the laboratory and commercial manufacturing. Analytical expertise allows the testing and analysis of raw materials, lab scale batches and ultimately the finished product.

The center was designed with leading-edge equipment and improvements to streamline the R&D process.

Lake Forest, Illinois
Akorn's corporate headquarters is located at 1925 West Field Court, Suite 300, Lake Forest, Illinois.

Gurgaon, India
Akorn India is a wholly owned subsidiary of Akorn Inc. whose international headquarters are located in Gurgaon, India. Akorn India is engaged two business activities:

• Development and marketing of its own portfolio of multi-source and branded pharmaceutical products in Asia, LATAM, CIS, Africa, Middle East regions
• Contract research and manufacturing of sterile pharmaceuticals